News Releases

Mar 21, 2020

Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test

First Rapid, Point-of-Care and Near-Patient Molecular Test for Detection of Virus that Causes COVID-19
Feb 28, 2020

Cepheid and Sherlock Biosciences Establish Collaboration on New GeneXpert Tests for Infectious Diseases and Oncology Leveraging CRISPR Technology
Feb 10, 2020

Cepheid Announces Development of Test for New Coronavirus Strain (2019-nCoV)
Oct 2, 2019

Cepheid Receives FDA Clearance for Xpert® BCR-ABL Ultra Test

Enabling on-demand monitoring of BCR-ABL levels in patients with Chronic Myeloid Leukemia (CML)
May 29, 2019

Cepheid Receives FDA Clearance for Extragenital Claims for Xpert® CT/NG Test

On-Demand Same-Day Extragenital Testing for Chlamydia and Gonorrhea Fills Critical Unmet Need in Fight Against Rising Rates of Chlamydial and Gonorrheal Infection

Show per page